Driehaus Capital Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Driehaus Capital Management’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-20,000	Closed	-$679K	–	607
2019 Q3	$679K	Buy	+20,000	New	+$592K	0.02%	378
2019 Q2	–	Sell	-150,123	Closed	-$3.48M	–	552
2019 Q1	$3.48M	Sell	150,123 -32,065	-18%	-$839K	0.13%	172
2018 Q4	$3.82M	Sell	182,188 -60,923	-25%	-$1.5M	0.16%	159
2018 Q3	$9.41M	Buy	243,111 +7,715	+3%	+$285K	0.29%	109
2018 Q2	$9.26M	Buy	+235,396	New	+$6.93M	0.31%	100

Other funds holding DCPH

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Driehaus Capital Management's DCPH Position: Q4 2019 in Review

Driehaus Capital Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2019, closing a stake of 20,000 shares — an estimated $679K sold.

Driehaus Capital Management first reported a position in DCPH in Q2 2018 and held it in 5 quarters. The position peaked at $9.41M in Q3 2018. 153 funds tracked by Wall St. Rank hold DCPH as of Q4 2019.

Driehaus Capital Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Driehaus Capital Management sold 20,000 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $679K.
Driehaus Capital Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 5 quarters.
Driehaus Capital Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $9.41M in Q3 2018.
153 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Driehaus Capital Management's 13F filing for Q4 2019, filed 12 Feb 2020.